Clinical Trials Directory

Trials / Completed

CompletedNCT04035187

Itraconazole Oral Absorption

Prediction of Itraconazole Oral Absorption From In Vitro Dissolution

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
17 (actual)
Sponsor
University of Maryland, Baltimore · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

For tablets to be absorbed, the drug must dissolve after being swallowed. Drugs with low solubility sometimes require the inert ingredients in tablets to help the drug dissolve after being swallowed. This study uses itraconazole as an example drug with low solubility. Itraconazole tablets with different inert ingredients and manufacturing will be administered to healthy volunteers to see if the different inert ingredients and manufacturing impact drug absorption.

Conditions

Interventions

TypeNameDescription
DRUGfast itraconazole tablet100mg dose
DRUGmedium itraconazole tablet100mg dose
DRUGslow itraconazole tablet100mg dose
DRUGoral itraconazole solution100mg dose

Timeline

Start date
2020-02-10
Primary completion
2022-05-21
Completion
2022-05-21
First posted
2019-07-29
Last updated
2023-10-05
Results posted
2023-10-05

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04035187. Inclusion in this directory is not an endorsement.